The Korea Herald will host the 2025 US Strategy Roundtable for Pharma and Biotech at the Korea Chamber of Commerce and Industry in Seoul on Tuesday.
The roundtable will bring together key players in the biopharmaceutical industry, including leading firms and innovative biotech startups aiming to expand into the US and global markets.
Former Justice Minister Kang Kum-sil, now a partner at One Law Partners, will deliver the opening address. The keynote presentation will be given by Kurt Tong, managing partner at The Asia Group, a Washington-based strategic and investment advisory firm.
The two-hour session will provide a focused platform for discussing how Korea’s biotech and pharma sectors can align with evolving US policy dynamics and strengthen cross-border partnerships.
▶ Date: April 29 (Tuesday) 9:30 a.m. - 12:00 p.m.
▶ Venue: Korea Chamber of Commerce and Industry, Meeting Room 3
▶ Organizers: One Law Partners / Korea Bio
▶ Inquiries: Forum secretariat (Tel: 02-727-0206)
hykim@heraldcorp.com
